Apoptosis can be induced by activating/stabilizing p53, and by inhibiting NF-κB. Now, it has been found that a surprising number of small molecules can do both. This article describes the principles behind such dual activity, discusses current candidate molecules and provides an outlook to their future development as anticancer drugs.
- Anwesha Dey
- Vinay Tergaonkar
- David P. Lane
